Home LiteratureArticle Details
PMID: 3185582 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The induction and repair of lesions produced by the photolysis of (6-4) photoproducts in normal and UV-hypersensitive human cells.

Mutation research ·Vol. 194 ·No. 3 ·1988-11-00 ·Pages 227-37

Mitchell DL

Abstract

A radioimmunoassay was used to study the induction and repair of damage produced by the photolysis of (6-4) photoproducts in normal and UV-sensitive human cells. Photochemical conditions were established to optimize the production of photolyzed (6-4) photoproducts in human cell DNA with minimal induction of other photoproducts. The repair of this photoproduct, presumed to be a Dewar pyrimidinone, was similar to that determined for the (6-4) photoproduct, with most of the antibody-binding sites removed within 4 h post-photolysis. Whereas xeroderma pigmentosum group A cells were deficient in the repair of this lesion, an XP variant and two cell lines selectively hypersensitive to UVB-irradiation were shown to have normal repair. The radioimmunoassay was further used to demonstrate the alkali-lability of the (6-4) photolysis product.

MeSH Terms
DNA Repair Humans In Vitro Techniques Osmium Tetroxide Photolysis Pyrimidine Dimers/metabolism Radioimmunoassay Spectrum Analysis Ultraviolet Rays
Chemicals
Pyrimidine Dimers Osmium Tetroxide
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Mitchell D L
University of Texas System Cancer Center, Smithville 78957.
Article Info
Journal
Mutation research
Abbr.
Mutat Res
ISSN
0027-5107
Published
1988-11-00
Pages
227-37
Language
English
Region
Netherlands
NLM ID
0400763
Subset
IM
Grants
NCI NIH HHS · CA 24540 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com